Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01775423 · ClinicalTrials.gov registry record · Phase 1
A Study of BBI608 in Adult Patients With Advanced Malignancies
A Phase 1 study, sponsored by Sumitomo Pharma America.
- Completed
- Registry status
- Phase 1
- Development phase
- 87
- Enrollment target
NCT01775423: Completed Phase 1 study, sponsored by Sumitomo Pharma America.
NCT01775423 is a Phase 1 study that has completed, run by Sumitomo Pharma America. The registered enrollment target is 87 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (45% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01775423, a Phase 1 study, has completed, sponsored by Sumitomo Pharma America.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 87 participants
- Enrollment target
Study Summary
This is an open label, single arm, dose escalation study of BBI608 in patients with advanced malignancies.
Primary Outcome
Assessment of safety of BBI608 given in monotherapy to patients with advanced malignancies by reporting of adverse events and serious adverse events
Interventions
- DRUG BBI608
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 87 participants |
| Start Date | 2009-03 |
| Est. Completion | 2015-08-06 |
| Phase | Phase 1 |
What the finished NCT01775423 record still lists
NCT01775423 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 87 participants, a relatively small participant target, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (45% higher).
The record links to 0 conditions, and to 1 intervention - of which BBI608 is the first listed.
NCT01775423 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01775423 about?
NCT01775423 is a clinical study titled "A Study of BBI608 in Adult Patients With Advanced Malignancies". This is an open label, single arm, dose escalation study of BBI608 in patients with advanced malignancies.
What is the current status of trial NCT01775423?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 87 participants. The study started on 2009-03. Estimated completion is 2015-08-06.
What interventions are being tested in trial NCT01775423?
The interventions under investigation include: BBI608 (DRUG).
Who is sponsoring clinical trial NCT01775423?
This trial is sponsored by Sumitomo Pharma America, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01775423's enrollment target sits among peer trials
87 651st of 2000 higher than 1,349 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03292601 · 87 participants · NA
Brace Monitoring for Adolescent Idiopathic Scoliosis (AIS)
- NCT04291105 · 87 participants · Phase 2
Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients
- NCT04565795 · 87 participants · NA
Safety and Device Performance of the Uriprene® Degradable Temporary Ureteral Stent Following Uncomplicated Ureteroscopy
- NCT05607004 · 87 participants · Phase 2
(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia